Current MEG Announcements
It was great to see so many MEG members and those from other fields of cancer research recently at the AACR Annual Meeting 2019 in Atlanta, Georgia! To view webcasts from this major event, see here. We look forward to seeing many of you at next year's Annual Meeting in San Diego, California, April 24-29, 2020.
Photos of the MEG Town Hall at the AACR Annual Meeting 2019
(at left) MEG Chairperson 2018-2019, Dr. Ellen L. Goode, is recognized for her service by MEG Chairperson-elect, Dr. Shelley S. Tworoger, at the MEG Town Hall Meeting on Monday, April 1.
It was a stimulating and entertaining evening for the MEG membership (and those from other fields of cancer research) at the MEG Town Hall at the AACR Annual Meeting 2019. After an interesting presentation on her vision for the journal Cancer Epidemiology, Biomarkers & Prevention, given by Editor-in-Chief, Dr. Elizabeth A. Platz and the featured program, "Developing Transdisciplinary Relationships in Population Studies," given by Dr. Sarah Gehlert, everyone enjoyed refreshments and great networking to extend the program. See additional photos here.
Congratulations to the 2019 MEG Scholar-in-Training Awardees
Best wishes for continued success to our 2019 MEG Scholar-in-Training Award recipients Drs. Xiang Shu; Audrey Jung; and Konrad Stopsack! Their awards (known as 'SITAs') were presented during the AACR Annual Meeting 2019. Learn more about this award and this year's awardees. MEG members, did you know that the MEG annual membership dues help to support these three awards to allow early-career researchers to participate in the AACR Annual Meeting each year? Thank you for your continued support to early-career scientists.
Request for Proposals for Genome-wide Investigation of Late-effects Using the Childhood Cancer Survivor Study (CCSS) Cohort
The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.
Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1).
Learn more details regarding the application process as well as the application for data access.
From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
The Epidemiology and Genomics Research Program
in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars.
To learn more about the EGRP's webinar series, visit the SeqSPACE Upcoming Topics and Speakers webpage.
Request for Information to Facilitate Cancer Systems Epidemiology Research
The NCI's Epidemiology and Genomics Research Program would like to let you know about a “Request for Information (RFI) to Better Facilitate Cancer Systems Epidemiology Research.” This RFI is part of a larger planning effort to identify current challenges and set priorities for analytical approaches and data needs for population-based epidemiology studies of cancer risk and prognosis. For more information. Learn more. Responses to the RFI are due by April 30, 2019. Respond by email to: NCICancerSysEpi_RFI@mail.nih.gov; for questions, contact Leah Mechanic, PhD, MPH at firstname.lastname@example.org.
Liver Fibrosis to Cancer Workshop – April 22-23, 2019
The National Cancer Institute (NCI) Liver Cancer Working Group invites you to attend the Liver Fibrosis to Cancer Workshop from Monday, April 22 to Tuesday, April 23. This workshop includes researchers studying liver disease and cancer within the United States. Sessions will include basic science, epidemiology, early detection, and translational research/clinical trials with an emphasis on exploring opportunities where interventions are likely to marry basic research with translational (biomarkers, reversibility of fibrosis/cirrhosis) research. For more information about the workshop, visit the Workshop webpage. To register (required), please visit the registration webpage. For questions, please contact: Betsy Read-Connole, PhD: email@example.com.
MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts
MEG members receive a special 5 percent discount for publication fees only (not AuthorChoice) for articles accepted in Cancer Epidemiology, Biomarkers & Prevention (CEBP). This is in addition to the 5 percent discount given to all AACR members. Thus, MEG members receive a total discount of 10 percent. Just use the code "MEGAO2019" when receiving notification from the CEBP staff about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.
CancerCareers Discounts Available
Be sure to check out www.cancercareers.org for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.
To submit an announcement for consideration, please note:
Employment opportunities should be sent to cancercareers.org for posting consideration on that website. Please refer all questions regarding employment posting to
Postings of a non-employment nature may still be sent to firstname.lastname@example.org for review and possible future posting on the MEG Announcements.
Best regards from everyone at the AACR, and sincere appreciation for your